FindTrial
Sign In

A study to evaluate etiological factor in newly diagnosed female patients of Osteoarthritis (Sandhigatavata),as they are not separately mentioned,so it was decided to study common etiological factor of Vatavyadhi i.e suppression of urges of Defecation, Urination and flatus.

An observational study of suppression of urges of Defecation, Urination and Flatus as an etiological factor in newly diagnosed female patients of Sandhigatavata.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/09/021047
Enrollment
100
Registered
2019-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M150- Primary generalized (osteo)arthritis

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Pooja Prakash Bhingarde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group:18 to 70 years. 2.Gender-Only female patients will be selected irrespective of caste,occupation,socio-economic status. 3.Clinically diagnosed female patients of Sandhigatavata.

Exclusion criteria

Exclusion criteria: 1. Clinically diagnosed patients of Sandhivikara like Aamvata, Vatarakta, Kroshtukshirsh, Grudhrasi, Khanja, Pangulya. 2. Patients having Vatavyadhi other than Sandhigatavata. 3. Patients having any apparent major systemic complication or major diseases like Tuberculosis of joints, malignancy of bones. 4. Pregnant woman. 5. Adharniyavega- a) Shukra, b) Chardi, c) Shavathu, d) Udgar, e) Jrumbha, f) Kshudha, g) Trushna, h) Aashru, i) Nidra, j) Nishwas.

Design outcomes

Primary

MeasureTime frame
To study suppression of urges of Defecation, Urination and Flatus as an etiological factor in newly diagnosed female patients of Sandhigatavata.Timepoint: 1 year—

Secondary

MeasureTime frame
NoneTimepoint: NIL—

Countries

India

Contacts

Public ContactPooja Prakash Bhingarde

MAMs Sumatibhai Shah Ayurved Mahavidyala,

sb.bagore@gmail.com8605614599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026